Metabolic dysfunction–associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD), is a type of chronic...
135 KB (14,992 words) - 03:32, 5 August 2024
cirrhosis, liver cancer, and esophageal varices. The main subtypes of fatty liver disease are metabolic dysfunction–associated steatotic liver disease (MASLD...
38 KB (3,896 words) - 23:07, 12 September 2024
Cirrhosis (redirect from End-stage liver disease)
progressive form of metabolic dysfunction–associated steatotic liver disease, previously called non-alcoholic fatty liver disease or NAFLD), heroin abuse...
115 KB (11,932 words) - 02:09, 30 September 2024
cardiovascular disease. Chronically elevated serum triglyceride levels are a component of metabolic syndrome and metabolic dysfunction-associated steatotic liver disease...
18 KB (1,673 words) - 18:21, 28 July 2024
visceral fat into the liver, leading to hepatic insulin resistance and metabolic dysfunction–associated steatotic liver disease. Measuring approximately...
14 KB (1,383 words) - 19:30, 22 September 2024
Steatohepatitis (category Diseases of liver)
constitute fatty liver changes. There are 2 main types of fatty liver disease (FLD): Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) (previously...
6 KB (463 words) - 19:48, 13 September 2024
high-density lipoprotein (HDL). Metabolic syndrome is associated with the risk of developing cardiovascular disease and type 2 diabetes. In the U.S....
60 KB (6,850 words) - 17:24, 18 September 2024
Insulin-like growth factor 1 (section Liver fibrosis)
predicting fibrosis, but not steatosis, in people with metabolic dysfunction–associated steatotic liver disease. Medical conditions: acromegaly (especially when...
35 KB (4,573 words) - 09:59, 28 August 2024
Semaglutide (category Experimental drugs developed for non-alcoholic fatty liver disease)
lowering liver enzymes (transaminitis) and improving certain radiologically observed features of metabolic dysfunction–associated steatotic liver disease. French...
68 KB (5,595 words) - 15:33, 1 October 2024
SUCNR1 (section Liver diseases)
Sanyal AJ (September 2023). "Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient...
73 KB (9,236 words) - 23:47, 12 September 2024